What is Inhibrx Biosciences, Inc.'s free cash flow yield?

Inhibrx Biosciences, Inc. (INBX) reported free cash flow yield of -13.4% in Q1 2026.

How has Inhibrx Biosciences, Inc.'s free cash flow yield changed year-over-year?

Inhibrx Biosciences, Inc.'s free cash flow yield increased by 83.9% year-over-year, from -83.3% to -13.4%.

What does free cash flow yield mean?

Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.

Inhibrx Biosciences, Inc. INBX Free cash flow yield

Free cash flow yield at other companies

PfizerPFE

7.8%+4.6pp

Rogers CorporationROG

3.7%-0.7pp

Merck & Co.MRK

4.7%-2.8pp

Gilead SciencesGILD

5.9%-1.1pp

Nuvation BioNUVB

-9%-3.6pp

ImmunomeIMNM

-8.3%-3.4pp

Other financials

Income statement

See full

Revenue--100%

Operating income-$30.9M+27.9%

Net income-$33.4M+22.8%

EPS (diluted)-$2.15+23.2%

Balance sheet

See full

Cash & equivalents$161.7M-25.3%

Total debt$180.9M+69.8%

Total equity-$21.0M-122%

Total assets$184.0M-24.2%

Cash flow

See full

Operating cash flow-$38.0M-5.9%

CapEx--100%

Free cash flow-$38.0M-5.9%

Valuation

See full

Market cap$1.4B+546%

Enterprise value$1.42B+1,233%

P/S1,073.7×-280×

Profitability

See full

Operating margin-10,386.5%-5,025pp

Net margin-10,773.5%-878,492pp

FCF margin-9,986.5%-4,727pp

Returns & leverage

See full

Return on equity-197.8%-2,158pp

Debt / equity13.4×+13.3×

Current ratio6.5×+1.3×

Where this comes from

Calculated from Inhibrx Biosciences, Inc.’s reported figures.

free cash flow/market cap=-13.4%

Based on trailing twelve months.

The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inhibrx Biosciences, Inc.'s free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Inhibrx Biosciences, Inc.'s free cash flow yield?: Inhibrx Biosciences, Inc. (INBX) reported free cash flow yield of -13.4% in Q1 2026.
How has Inhibrx Biosciences, Inc.'s free cash flow yield changed year-over-year?: Inhibrx Biosciences, Inc.'s free cash flow yield increased by 83.9% year-over-year, from -83.3% to -13.4%.
What does free cash flow yield mean?: Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.